Lytix Biopharma ASA (OSL:LYTIX)
Norway
· Delayed Price · Currency is NOK 10.45
+0.15 (1.46%)
Apr 29, 2026, 11:49 AM CET
Lytix Biopharma ASA Market Cap
Lytix Biopharma ASA has a market cap or net worth of 792.07 million as of April 29, 2026. Its market cap has increased by 131.14% in one year.
Market Cap
792.07M
Enterprise Value
721.91M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10.45
Market Cap Chart
Since June 14, 2021, Lytix Biopharma ASA's market cap has increased from 720.55M to 792.07M, an increase of 9.93%. That is a compound annual growth rate of 1.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 792.07M | 17.44% |
| Dec 30, 2025 | 674.43M | 68.03% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zelluna ASA | 619.97M |
| ArcticZymes Technologies ASA | 1.02B |
| Nykode Therapeutics AS | 1.02B |
| Thor Medical ASA | 1.73B |
| Circio Holding ASA | 2.25B |
| SoftOx Solutions AS | 245.80M |
| Oncoinvent ASA | 221.23M |
| Arctic Bioscience AS | 93.27M |